-
This kind of stale analysis never points out that the U.S. since 1776 has almost always run fiscal and trade deficits.
FORBES: Second Thoughts on Paulson
-
Sterling Burnett, a senior fellow at the National Center for Policy Analysis, points out a basic conflict: Wind farms have to be places the winds blow steadily, which often also happen to be areas favored by raptors and migratory birds.
FORBES: Fact and Comment
-
As the Financial Times, which first published details of the shocking analysis, points out this morning, the troika paper talks of the need for banks and investors to agree to be repaid 50% or 60% less than the face value of what Greece owes them.
BBC: Greece needs yet another bailout
-
Other Indian tribes have had similar agreements, as Alan Meister, an economist with Analysis Group, points out.
ECONOMIST: Gambling
-
But Scott Zeger, the head of the department of biostatistics at Johns Hopkins, who performed the statistical analysis in the study, points out that clustered sampling is the rule rather than the exception in public-health studies, and that the patterns of deaths caused by epidemics are also very variable by location.
ECONOMIST: The Iraqi war
-
Mr Krugman, who pioneered formal economic analysis of what causes currency crises, points out that Asia's banks and finance companies operated with implicit government guarantees.
ECONOMIST: Disaster has spawned a new theory of financial crises
-
The latest analysis and forecast from the Item Club Scotland points out there are other telling comparisons closer to home.
BBC: Making up lost ground
-
Finally, if you can access a research report, read it to see if the analyst points out something you missed in your analysis.
FORBES: Analysts Pressured To Be Positive
-
But, as John Yinger, of Syracuse University, points out in the JEP symposium, regression analysis has drawbacks as a tool for measuring discrimination.
ECONOMIST: Race, sex and the dismal science
-
It points out that it did share its meta-analysis with regulators both in the U.S. and in Europe--although it declines to comment on the timing of those meetings.
FORBES: Open-Source Drug Safety?